Improving Colorectal Cancer Screening Rates in a Managed Care Health Plan

Recruitment of Provider Organizations for a Randomized Effectiveness Trial1

  1. Patricia A. Ganz2,
  2. Melissa M. Farmer,
  3. Michael Belman,
  4. Jennifer L. Malin,
  5. Roshan Bastani,
  6. Katherine L. Kahn,
  7. Allen Dietrich and
  8. Jonathan Fielding
  1. Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center [P. A. G., M. M. F., J. L. M., R. B., K. L. K.], Department of Health Services, School of Public Health [P. A. G., M. M. F., R. B., J. F.], and Departments of Medicine [P. A. G., J. L. M., K. L. K.] and Pediatrics [J. F.], School of Medicine, University of California, Los Angeles, California; Blue Cross of California, Woodland Hills, California [M. B.]; Senior Scientist, RAND, Santa Monica, California [K. L. K.]; and Department of Family Medicine, Dartmouth Medical School, Hanover, New Hampshire [A. D.]

    Abstract

    Evidence-based guidelines recommend regular colorectal cancer (CRC) screening for adults 50 years and older, yet screening rates remain very low. In this paper we describe the challenges associated with recruitment and retention of provider organizations (POs) for a group randomized, controlled effectiveness trial to increase CRC screening, among patients in a managed care health insurance plan. Using the health plan as the sampling frame, we recruited POs to test a facilitated quality improvement program to increase CRC screening. Defined eligibility and recruitment procedures were used as part of this process. We successfully recruited 36 POs over the course of 9 months; however, there were many challenges associated with the recruitment and retention process, including difficulties in (a) identifying the PO medical director and the individual authorized to agree to study participation, (b) making contact with the medical director, and (c) obtaining the materials necessary to initiate the study. All of these factors delayed the research substantially. Retention activities were also a major challenge in that one-third of the medical directors changed during the course of the intervention. This study benefited from a strong partnership between the health plan and the research group. Although many challenges exist, there are tremendous opportunities that result from the design and conduct of effectiveness research in existing POs. Successful implementation of programs that are feasible and take advantage of existing quality improvement mechanisms within the PO has potential to improve CRC screening rates and can have a major public health impact.

    Footnotes

    • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • 1 Supported by NIH/National Cancer Institute Grant R01 CA75544 and by an American Cancer Society Clinical Research Professorship (to P. A. G.).

    • 2 To whom requests for reprints should be addressed, at Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Drive South, CHS A2-125, Los Angeles, CA 90095-6900. Phone: (310) 206-1404; Fax: (310) 206-3566; E-mail: pganz{at}ucla.edu

    • 3 The abbreviations used are: CRC, colorectal cancer; PO, provider organization; QI, quality improvement.

      • Accepted May 12, 1903.
      • Received December 4, 1902.
      • Revision received April 28, 1903.
    « Previous | Next Article »Table of Contents